Anti-SARS-CoV-2 Monoclonal Antibody Distribution to High-risk Medicare Beneficiaries, 2020-2021

Caroline L. Behr; Karen E. Joynt Maddox; Ellen Meara; Arnold M. Epstein; E. John Orav; Michael L. Barnett

doi:10.1001/jama.2022.1243

Anti-SARS-CoV-2 Monoclonal Antibody Distribution to High-risk Medicare Beneficiaries, 2020-2021

Caroline L. Behr
, Karen E. Joynt Maddox
, Ellen Meara
, Arnold M. Epstein
, E. John Orav
, Michael L. Barnett

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	980-983
Number of pages	4
Journal	JAMA
Volume	327
Issue number	10
DOIs	https://doi.org/10.1001/jama.2022.1243
State	Published - Mar 8 2022

Access to Document

10.1001/jama.2022.1243

Cite this

@article{8a786aa7925a4f88b20a4064ac6ac2da,

title = "Anti-SARS-CoV-2 Monoclonal Antibody Distribution to High-risk Medicare Beneficiaries, 2020-2021",

author = "Behr, \{Caroline L.\} and \{Joynt Maddox\}, \{Karen E.\} and Ellen Meara and Epstein, \{Arnold M.\} and Orav, \{E. John\} and Barnett, \{Michael L.\}",

note = "Funding Information: Funding/Support: This work was supported by grant K23 AG058806 from the NIA to Dr Barnett and award U19 HS024075 from the Agency for Healthcare Research and Quality to Drs Meara and Barnett. Funding Information: Conflict of Interest Disclosures: Dr Joynt Maddox reported receipt of grants from the National Institutes of Health (NIH)/National Institute on Aging (NIA) and the NIH/National Heart, Lung, and Blood Institute and personal fees from Centene Corp for serving on a health policy advisory committee. No other disclosures were reported.",

year = "2022",

month = mar,

day = "8",

doi = "10.1001/jama.2022.1243",

language = "English",

volume = "327",

pages = "980--983",

journal = "JAMA",

issn = "0098-7484",

number = "10",

}

TY - JOUR

T1 - Anti-SARS-CoV-2 Monoclonal Antibody Distribution to High-risk Medicare Beneficiaries, 2020-2021

AU - Behr, Caroline L.

AU - Joynt Maddox, Karen E.

AU - Meara, Ellen

AU - Epstein, Arnold M.

AU - Orav, E. John

AU - Barnett, Michael L.

N1 - Funding Information: Funding/Support: This work was supported by grant K23 AG058806 from the NIA to Dr Barnett and award U19 HS024075 from the Agency for Healthcare Research and Quality to Drs Meara and Barnett. Funding Information: Conflict of Interest Disclosures: Dr Joynt Maddox reported receipt of grants from the National Institutes of Health (NIH)/National Institute on Aging (NIA) and the NIH/National Heart, Lung, and Blood Institute and personal fees from Centene Corp for serving on a health policy advisory committee. No other disclosures were reported.

PY - 2022/3/8

Y1 - 2022/3/8

UR - https://www.scopus.com/pages/publications/85124403938

U2 - 10.1001/jama.2022.1243

DO - 10.1001/jama.2022.1243

M3 - Letter

C2 - 35119452

AN - SCOPUS:85124403938

SN - 0098-7484

VL - 327

SP - 980

EP - 983

JO - JAMA

JF - JAMA

IS - 10

ER -

Anti-SARS-CoV-2 Monoclonal Antibody Distribution to High-risk Medicare Beneficiaries, 2020-2021

Access to Document

Other files and links

Cite this